426 related articles for article (PubMed ID: 10453568)
21. Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides.
Boehme MW; Schmitt WH; Youinou P; Stremmel WR; Gross WL
Am J Med; 1996 Oct; 101(4):387-94. PubMed ID: 8873509
[TBL] [Abstract][Full Text] [Related]
22. Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis.
Wiesner O; Russell KA; Lee AS; Jenne DE; Trimarchi M; Gregorini G; Specks U
Arthritis Rheum; 2004 Sep; 50(9):2954-65. PubMed ID: 15457464
[TBL] [Abstract][Full Text] [Related]
23. The utility of detecting of autoantibodies against neutrophil cytoplasmic components in Wegener's granulomatosis.
Chng HH; Ganz T; Saxon A
Ann Allergy; 1989 Nov; 63(5):411-6. PubMed ID: 2817531
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous manifestations of Wegener's granulomatosis: a clinicopathologic study of 17 patients and correlation to antineutrophil cytoplasmic antibody status.
Comfere NI; Macaron NC; Gibson LE
J Cutan Pathol; 2007 Oct; 34(10):739-47. PubMed ID: 17880578
[TBL] [Abstract][Full Text] [Related]
25. Detection of anti-neutrophil cytoplasmic antibodies under actual clinical testing conditions.
Russell KA; Wiegert E; Schroeder DR; Homburger HA; Specks U
Clin Immunol; 2002 May; 103(2):196-203. PubMed ID: 12027425
[TBL] [Abstract][Full Text] [Related]
26. Predictive value of antineutrophil cytoplasmic antibodies in small-vessel vasculitis.
Lurati-Ruiz F; Spertini F
J Rheumatol; 2005 Nov; 32(11):2167-72. PubMed ID: 16265696
[TBL] [Abstract][Full Text] [Related]
27. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens.
Sugi K; Saitoh O; Matsuse R; Tabata K; Uchida K; Kojima K; Nakagawa K; Tanaka S; Teranishi T; Hirata I; Katsu K
Am J Gastroenterol; 1999 May; 94(5):1304-12. PubMed ID: 10235211
[TBL] [Abstract][Full Text] [Related]
28. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic specificity of anti-neutrophil cytoplasmic antibodies (ANCA) in otorhinolaryngological diseases.
Fukase S; Ohta N; Inamura K; Kimura Y; Aoyagi M; Koike Y
Acta Otolaryngol Suppl; 1994; 511():204-7. PubMed ID: 8203230
[TBL] [Abstract][Full Text] [Related]
30. Relative importance of CCR5 and antineutrophil cytoplasmic antibodies in patients with Wegener's granulomatosis.
Zhou Y; Huang D; Farver C; Hoffman GS
J Rheumatol; 2003 Jul; 30(7):1541-7. PubMed ID: 12858455
[TBL] [Abstract][Full Text] [Related]
31. Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis.
Choi HK; Merkel PA; Tervaert JW; Black RM; McCluskey RT; Niles JL
Arthritis Rheum; 1999 Feb; 42(2):384-8. PubMed ID: 10025935
[TBL] [Abstract][Full Text] [Related]
32. Increasing incidence of Wegener's granulomatosis in Sweden, 1975-2001.
Knight A; Ekbom A; Brandt L; Askling J
J Rheumatol; 2006 Oct; 33(10):2060-3. PubMed ID: 16960922
[TBL] [Abstract][Full Text] [Related]
33. Antineutrophil cytoplasmic autoantibody testing in vasculitides.
Gross WL
Rheum Dis Clin North Am; 1995 Nov; 21(4):987-1011. PubMed ID: 8592745
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of anti-neutrophil cytoplasm antibodies detected by a standardized indirect immunofluorescence assay.
Davenport A; Lock RJ; Wallington TB; Feest TG
Q J Med; 1994 May; 87(5):291-9. PubMed ID: 7938409
[TBL] [Abstract][Full Text] [Related]
35. High-sensitivity detection of autoantibodies against proteinase-3 by a novel third-generation enzyme-linked immunosorbent assay.
Roggenbuck D; Buettner T; Hoffmann L; Schmechta H; Reinhold D; Conrad K
Ann N Y Acad Sci; 2009 Sep; 1173():41-6. PubMed ID: 19758130
[TBL] [Abstract][Full Text] [Related]
36. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides.
Sinclair D; Stevens JM
Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028
[TBL] [Abstract][Full Text] [Related]
37. Value of a new automated fluorescence immunoassay (EliA) for PR3 and MPO-ANCA in monitoring disease activity in ANCA-associated systemic vasculitis.
Sinico RA; Radice A; Corace C; DI Toma L; Sabadini E
Ann N Y Acad Sci; 2005 Jun; 1050():185-92. PubMed ID: 16014533
[TBL] [Abstract][Full Text] [Related]
38. Use of highly sensitive C-reactive protein for followup of Wegener's granulomatosis.
Kälsch AI; Csernok E; Münch D; Birck R; Yard BA; Gross W; Kälsch T; Schmitt WH
J Rheumatol; 2010 Nov; 37(11):2319-25. PubMed ID: 20716656
[TBL] [Abstract][Full Text] [Related]
39. Ceruloplasmin levels in antineutrophil cytoplasmic antibody-positive patients.
Baskin E; Bakkaloglu A; Besbas N; Hascelik G; Saatci U; Gök F; Ozen S
Pediatr Nephrol; 2002 Nov; 17(11):917-9. PubMed ID: 12432434
[TBL] [Abstract][Full Text] [Related]
40. [Anticytoplasm antibodies of polymorphonuclear neutrophils in Wegener's granulomatosis, other autoimmune diseases, and in patients undergoing hemodialysis].
Arana RM; Hübscher O; Eimon A; Casanova MB; Fonseca R; Turin M
Medicina (B Aires); 1993; 53(2):113-6. PubMed ID: 8295526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
